Article
Immunogenomic engineering of a plug-and-(dis)play hybridoma platform
17 Aug 2016
Abstract excerpt
Hybridomas, fusions of primary mouse B cells and myelomas, are stable, rapidly-proliferating cell lines widely utilized for antibody screening and production. Antibody specificity of a hybridoma clone is determined by the immunoglobulin sequence of the primary B cell. Here we report a platform for rapid reprogramming of hybridoma antibody specificity by immunogenomic engineering. Here we use CRISPR-Cas9 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
